Angiotensin II and Inflammation: The Effect of ACE Inhibition and Angiotensin II Receptor Blockade
Authors:
- Sandeep DhindsaSDSandeep Dhindsa
- Rajesh GargRGRajesh Garg
- Arindam BandyopadhyayABArindam Bandyopadhyay
- Paresh DandonaPDParesh Dandona
- 1 December 2003
- journal article
- research article
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 1 (4) , 255-259
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.Keywords
This publication has 38 references indexed in Scilit:
- NF-κB Activation is Essential for Angiotensin II-dependent Proliferation and Migration of Vascular Smooth Muscle CellsJournal of Molecular and Cellular Cardiology, 2002
- Angiotensin II AT1 receptor antagonists and platelet activationNephrology Dialysis Transplantation, 2001
- Tissue Angiotensin and Pathobiology of Vascular DiseaseHypertension, 2001
- Angiotensin II Activates Nuclear Transcription Factor κB Through AT1and AT2in Vascular Smooth Muscle CellsCirculation Research, 2000
- Angiotensin II Stimulates Endothelial Vascular Cell Adhesion Molecule-1 via Nuclear Factor-κB Activation Induced by Intracellular Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Angiotensin II Activates the Proinflammatory Transcription Factor Nuclear Factor-κB in Human MonocytesBiochemical and Biophysical Research Communications, 1999
- Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.Journal of Clinical Investigation, 1997
- Cross-talk between the insulin and angiotensin signaling systems.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Lisinopril and nifedipine administration inhibits the ex vivo uptake of [45Ca2+] by platelets from hypertensive diabetic patients.British Journal of Clinical Pharmacology, 1992